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DObjectives: To determine rate of reoperation subsequent to primary valve repair in a pediatric population.
Methods: Between 1996 and 2009, 142 consecutive patients underwent aortic valve repair in our institution.
Median age at surgery was 9 years, with 30 being younger than age 1 year. Indication for surgery was stenosis
(n¼ 76), regurgitation (n¼ 55), and both (n¼ 11). Forty-six patients underwent repair with no addition of patch,
whereas 96 patients required addition of patches of glutaraldehyde preserved autologous pericardium for cusp
extension (n ¼ 51) and other repair (n ¼ 45).
Results: In the early postoperative period after cusp extension repair, 2 patients had a sudden unexplained death
and 1 had cardiac arrest requiring mechanical support and heart transplantation. Two additional patients with
cusp extension displayed signs of coronary ischemia. After a mean follow-up of 3.4  3.5 years, only 1 patient
died of a noncardiac cause. Seven-year freedom from reoperation was 80% (95% confidence interval [CI],
66-89). By multivariate analysis, the only predictors of reintervention were cusp extension (hazard ratio
[HR], 5.4; 95% CI, 1.7-16.8; P ¼ .004) and infants (HR, 5.6; 95% CI, 1.7-18.4; P ¼ .005). At final echocar-
diography follow-up, 23 of 119 survivors without reoperation had moderate (19%), 1 had moderate-severe
(1%), and 1 had severe regurgitation (1%), whereas 12 (10%) had a moderate degree of stenosis.
Conclusions: Aortic valve repair in pediatric populations is effective in postponing reintervention. The longev-
ity of the repair is shorter after cusp extension and when performed in infants. Caution should be used when
performing tricsupidization and cusp extension of bicuspid valves because it can be responsible for mortality
related to occlusion of the coronary ostia by patches. (J Thorac Cardiovasc Surg 2013;145:461-9)During the past 3 decades, decision making in aortic valve
disease for pediatric populations has been influenced by the
emergence of new techniques, but long-term outcomes have
been difficult to compare.1 In the mid-1980s, techniques of
aortic balloon valvuloplasty were developed.1,2 This field
saw a rapid expansion and it seems that interventional
catheterization is today the primary treatment modality in
most centers worldwide.3 In the best hands, this procedure
can yield a freedom from reintervention of up to 50%
for around 10 years in children and adolescents.4 Today
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The Journal of Thoracic and CaAssociation guidelines5 preclude the use of balloon valvulo-
plasty in adults, but it remains a standard treatment in chil-
dren and adolescents. The Ross procedure was popularized
in the mid-1990s, and it is only recently that we gained
perspective on the longevity of this procedure.6,7
Disappointingly, because of the progressive dilatation of
pulmonary autografts, a quarter of these patients may
require reintervention on the autograft within 2 decades of
the procedure. It is yet unclear if these results of the Ross
procedure will be similar or worse in a pediatric
population because all published series have reported
outcomes in a mixed population of children and young
adults. Some techniques of surgical valvuloplasty have
existed for many years, but this field has only known its
real expansion in the past decade, after the adult
techniques of valve repair were better delineated.8 Only
some isolated reports of valve repair with cusp extension
in a pediatric population have been published and it remains
difficult to evaluate the indications of aortic valve repair in
the armamentarium of the available techniques.9-11
During the past decades, our center has progressively
adopted a policy favoring primary aortic valve repair in pedi-
atric patients with aortic valve disease. We decided to inves-
tigate the long-term outcomes of this policy to determine its
efficacy in terms of survival and freedom from reoperation.rdiovascular Surgery c Volume 145, Number 2 461
FIGURE 1. Aortic valve procedures.




The design of the study was approved by the local Human Research
Ethics Committee and the need for consent was waived because of the ret-
rospective nature of the study. The files of all patients undergoing an aortic
valve repair at the Royal Children’s Hospital, Melbourne, were reviewed.
The aim of the study was to determine outcomes of contemporary tech-
niques of aortic valve repair in a biventricular circulation and, therefore,
patients undergoing single ventricle palliation were excluded. Between
1996 and 2009, a total of 239 patients underwent an aortic valve proce-
dure. The 19 patients whose surgery was limited to a simple commissur-
otomy, and the 21 affected by rheumatic heart disease whose outcomes
may depend on their underlying disease, were excluded. Over the same
time period, 57 patients underwent primary balloon valvuloplasty, 97
underwent a Ross procedure, and 142 underwent an aortic valve repair
(Figure 1). During the initial period, surgery and catheter interventions
were offered concomitantly and progressively, and patients were preferen-
tially referred to surgery. Patients were considered candidates for an aortic
valve repair if the hinge point of the leaflets was still mobile, notwith-
standing the amount of fibrosis found on the remaining leaflets. All nod-
ular fibrosis was resected, and if the amount of remnant leaflet tissue did
preclude a repair with a minimal use of patches, a cusp extension tech-
nique was used. The 142 consecutive patients who successfully underwent
an aortic valve repair in our institution (38 girls, 104 boys) constitute the
core of this study.
The median age at time of aortic valve repair was 9 years (range, 0-20
years). Thirteen of these were neonates (age 30 days), 17 were infants
(age range, 31-267 days), 101 were aged between 1 and 18 years, and 11
were older than age 18 years.
The etiology of valve disease was congenital in 138 patients (97%) and
endocarditis in 4 patients. The primary indication for surgery was aortic
insufficiency in 55 patients, aortic stenosis in 76 patients, and mixed aortic
stenosis and insufficiency in 11 patients. Table 1 displays the primary indi-
cation for surgery by age group.
Forty-five patients had a prior cardiac intervention. Among those, 27
patients (19%) had a previous intervention on the aortic valve: 10 had
a previous commissurotomy, and 17 had a balloon valvuloplasty. Addi-
tional previous cardiac procedures were coarctation repair (n ¼ 8), ven-
tricular septal defect closure (n ¼ 6), relief of left ventricular outflow
tract obstruction (n ¼ 5), aortic arch repair (n ¼ 2), and arterial switch
operation (n ¼ 1).462 The Journal of Thoracic and Cardiovascular SurgThirty-nine patients had an additional 48 procedures performed con-
comitantly to the valve repair: ventricular septal defect closure (n ¼ 17),
relief of left ventricular outflow tract obstruction (n¼ 16), aortic arch repair
(n ¼ 6), mitral valve repair (n ¼ 4), partial anomalous pulmonary valve
drainage repair (n ¼ 1), relief of supra-aortic stenosis (n ¼ 2), postswitch
repositioning of a coronary artery (n ¼ 1), and pulmonary valve repair
(n ¼ 1). Cardiopulmonary bypass and crossclamp times were 119  42
minutes and 86  33 minutes, respectively.
The aortic valve was unicuspid in 7 patients, bicuspid in 87 patients,
and tricuspid in 48 patients. The 7 patients with a unicuspid valve
underwent a re-creation of neocommissures with pericardial patches.
Thirty-five of the 87 bicuspid valves were made tricuspid and 52 were
left bicuspid. Fifty-one patients had a cusp extension performed. Out of
these, 3 patients had extension of 1 cusp, 7 patients had extension of 2
cusps, and the remaining 41 had extension of three cusps. Thirty-three pa-
tients had a tricuspidization of a bicuspid valve with an extension of the 3
re-created cups. Forty-five patients had use of pericardial patch material
for a purpose other than cusp extension. In 17 patients, these patches
were used to repair a perforation in the cusp and in 28 patients patches
were used to re-create a single neocommissure (including 3 unicuspid valves).
The remaining 46 patients underwent repair without addition of any peri-
cardial patch material. They had a total of 62 procedures performed: com-
missurotomy and extensive resection of nodular dysplasia and thinning of
leaflets (n ¼ 26), triangular resection of free edge (n ¼ 19), subcommis-
sural annuloplasty (n ¼ 7), free edge plication (n ¼ 8), and repair of per-
forated leaflet using interrupted suture (n ¼ 2). Our surgical techniques
have been previously described.12 All patches used were made of autolog-
uous pericardium treated with 0.625% glutaraldehyde. The patches were
treated in a dish with a lid allowing the pericardium to be maintained flat
and were subjected to a first bath of 2 minutes. The lid was then removed
and the pericardium was turned over and treated for an additional 6
minutes. Over the course of the study, the second exposure to glutaralde-
hyde was reduced to 2 minutes. The patches were then rinsed 3 times for 3
minutes in normal saline. In the final rinse, 960 mg magnesium chloride
was added per liter of normal saline. The patches were cut in equal rect-
angular shapes for symmetric tricuspid valves, and adapted to the need for
asymmetrical valves. The height of the patch was not estimated in a stan-
dard fashion, but was left to the individual surgeon’s discretion. All
patients undergoing a repair were anticoagulated with 5 mg/kg aspirin
for the first 2 postoperative months.ery c February 2013
TABLE 1. Primary indication for surgery by age group*
Neonates and infants Noninfants Total
AS 29 (97) 47 (42) 76
AI 1 (3) 54 (48) 55
AS/AI 0 (0) 11 (10) 11
Total 30 112 142
Data are presented as n (%). AS, Aortic stenosis; AI, aortic insufficiency. *Neonates
and infants were considered children aged 1 year and younger. Noninfants were
children aged 1 year or older.
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DHospital mortality was defined as death before hospital discharge or
within 30 days of the surgery. Late mortality was defined as death after dis-
charge or>30 days from the first valve operation. Early reinterventions
were defined as any operation on a previous valve repair or replacement
before hospital discharge and were considered separate to late reoperations
occurring after hospital discharge. Reporting of valve-related outcomes,
such as valve thrombosis and bleeding events, were based on published
guidelines.13
Follow-up information was gathered from the hospital database or
collected from their referring cardiologists.
Statistical Analysis
Statistical analysis was performed using Stata 10 (StataCorp, College
Station, Tex). Parametric data were expressed as mean  standard devia-
tion and median (interquartile range). All tests of a patient’s characteristics
were 2-tailed. Risk factors for time-related outcomes such as late mortality,
reintervention, and valve replacement were tested from the date of first
valve surgery using Cox regression analysis. All pre- and perioperative
variables were tested for their association with reintervention and valve
replacement (Table 2). Univariate analysis identified variables most likely
to be associated with the given event, which were then entered in a stepwise






Aortic regurgitation .971 0.98
Aortic stenosis .806 1.13
Mixed aortic stenosis/aortic regurgitation .633 0.66
Concomitant cardiac procedure .256 0.48
Previous cardiac surgery .963 1.03
Age at surgery (d) .229 0.99
Age<1 y at time of surgery .048 2.89
Cusp extension technique .020 3.34
Use of patch (excluding cusp extension) .231 2.82
Initial valve morphology
Unicuspid valve .908 1.14
Bicuspid valve .581 1.34
Tricuspid valve .535 0.71
Body surface area .229 0.56
Crossclamp time .344 1.01
Bypass time .087 1.01
Significant regurgitation before surgery .260 1.78
Significant stenosis before surgery .887 0.93
Mean peak gradient before surgery .847 1.03
Boldface types indicates values reaching a P value< .05 by univariate (freedom from valv
ratio; CI, confidence interval.
The Journal of Thoracic and CaRESULTS
There were 3 early deaths (2%). Two deaths occurred
suddenly after hospital discharge, 4 and 17 days after repair
in a 7-year old and a 14-year old diabetic, respectively, both
of whom had undergone a cusp extension technique. The
third death occurred in a neonate with poor ventricular func-
tion 10 days postoperatively due to extensive brain damage
most likely related to an embolus occurring during his post-
operative mechanical support.
An additional 3 patients developed postoperative signs of
myocardial ischemia after cusp extensions. One patient
experienced sudden cardiac arrest on his first postoperative
day in the intensive care unit. Extracorporeal membrane
oxygenation was instituted under cardiopulmonary resusci-
tation with central cannulation via sternotomy and 9 days
later, a Thoratec paracorporeal ventricular assist system
(Thoratec Corp, Pleasanton, Calif) was inserted. After 58
days of support, he underwent an orthotopic heart transplan-
tation. One 3-year old patient had recurrent electrocardio-
graphic signs of ischemia, without clinical symptoms. The
electrocardiographic changes subsided spontaneously after
hospital discharge. The final patient who underwent a tricus-
pidisation of a bicuspid valve with cusp extension suffered
intractable ventricular fibrillation after removal of the cross-
clamp. Transoesophageal echocardiography raised the sus-
picion of the interference of the left main coronary ostium
with its extended cusp. The aortic valve was exposed, the
cusp facing the left main coronary orifice was slightlyervention Freedom from valve replacement
95% CI P value HR 95% CI
0.34-3.14 .721 0.81 0.25-2.64
0.36-2.71 .865 1.09 0.39-3.07
0.42-3.06 .994 1 0.36-2.78
0.08-5.48 .748 0.71 0.09-5.89
0.13-1.75 .132 0.31 0.07-1.42
0.36-2.93 .82 1.13 0.39-3.28
0.99-1.00 .38 0.99 0.99-1.00
1.00-8.3 .122 2.37 0.79-7.08
1.20-9.29 .011 3.95 1.36-11.5
0.52-15.4 .377 2.2 0.38-12.7
0.13-10.0 .859 1.21 0.14-10.8
0.47-3.82 .377 1.64 0.54-4.96
0.24-2.11 .324 0.55 0.17-1.80
0.22-1.44 .098 0.43 0.15-1.17
0.99-1.02 .344 1 0.99-1.02
0.99-1.02 .087 1.01 0.99-1.02
0.65-4.81 .388 1.57 0.57-4.33
0.35-2.46 .717 0.83 0.31-2.25
0.74-1.44 .858 1.03 0.73-1.45
e replacement) and multivariate (freedom from reintervention) analysis. HR, Hazard
rdiovascular Surgery c Volume 145, Number 2 463
FIGURE 2. Perioperative imaging by transoesophageal echocardiography with illustration. A, Bicuspid aortic valve. B, Tricuspidization with cusp exten-
sion resulting in the prolapse of the leaflet patch on the coronary ostium. C, After trimming of the left coronary cusp and resuspension of the facing com-
missure between the right and the noncoronary cusp the coaptation of the 3 leaflets is displaced centrally relieving ostial occlusion. LCA, Left coronary
artery.
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Dtrimmed, and the facing re-created commissure between the
noncoronary and the right coronary cusp was resuspended
to displace centrally the coaptation point between the three
leaflets (Figure 2). The patient subsequently showed no
more signs of ischemia. Following this event, we reviewed
the operative details and all echocardiographic examina-
tions of the 3 cases showing postoperative signs of ischemia
and the 2 patients who experienced sudden death. All
patients had tricuspidisation of a bicuspid valve with cusp
extension. An exact mechanism leading to myocardial
ischemia could not be identified, but interference of the
patches with the coronary orifices could not be ruled out.464 The Journal of Thoracic and Cardiovascular SurgThere was 1 early reintervention on the aortic valve
during the same hospital stay. One neonate remained in
the hospital with poor ventricular function and required
a Ross procedure 2 months after his initial valve repair.
One patient required a chest reexploration for bleeding, 1
experienced a complete heart block and required a pace-
maker implantation, and 1 patient experienced a pulmonary
hemorrhage and a stroke with complete recovery.
The mean follow-up in hospital survivors was 3.4  3.5
years and extended to 14 years. Only 2 patients were lost
to follow-up and completeness of follow-up was 99%. Con-
current (2008-2011) completion of follow-up was 80%ery c February 2013
FIGURE 3. Late outcomes. A, Kaplan-Meier freedom from reinterven-
tion. B, Kaplan-Meier freedom from reintervention in those with and
without cusp extension. C, Kaplan-Meier freedom from valve replace-
ment.
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D(114 out of 142). One patient aged 21 years died in a motor
vehicle accident 6 years after his valve repair. Survival at 1
and 10 years were, respectively, 98% (95% confidence
interval [CI], 93%-99%) and 95% (95% CI, 82%-98%).
No subsequent neurologic or thromboembolic events were
reported during follow-up.
Freedom From Reintervention
Eighteen patients had a late reintervention after a median
of 3.6 years (range, 1-7 years). Eleven were Ross proce-
dures, 3 had a mechanical valve replacement, 3 had
a re-repair, and 1 underwent a Bentall procedure. The indi-
cations for reintervention were aortic stenosis in 8 patients,
insufficiency in 6 patients, endocarditis in 2 patients, and
mixed stenosis and regurgitation in 2 patients. Two patients
underwent a Ross procedure 5 and 6 years, respectively,
after these reinterventions.
Freedom from reintervention at 1, 5, and 7 years, respec-
tively, were 97% (95% CI, 92%-98%), 87% (95% CI,
76%-93%), and 80% (95% CI, 66%-89%) (Figure 3, A).
Multivariate analysis identified the following predictors
for reintervention: cusp extension technique (hazard ratio
[HR], 5.4; 95% CI, 1.7-16.8; P ¼ .004) and being younger
than age 1 year at time of repair (HR, 5.6; 95% CI, 1.7-18.4;
P ¼ .005) (Table 2). The freedom from reintervention was
90%  5% (95% CI, 75%-96%) at 7 years for those
who had no cusp extension, compared with 66%  11%
(95% CI, 40%-83%) at 7 years for those who had a cusp
extension (Figure 3, B).
Freedom From Valve Replacement
Seventeen patients underwent a valve replacement. The
mean interval between initial repair and valve replacement
was 6  4 years. The freedom from valve replacement was
81%  6% (95% CI, 65-90) at 7 years (Figure 3, C). Uni-
variate analysis identified having a cusp extension (HR, 3.9;
95% CI, 1.3-11.4; P¼ .011) as the only predictor of having
a future valve replacement (Table 2).
Late Valvular Function
At final follow-up, 119 patients were surviving with their
native valve. Twenty-three had moderate regurgitation, 1
had moderate to severe regurgitation, and 1 had severe aor-
tic valve regurgitation. Twelve patients were described as
having moderate stenosis or more and had an average
peak gradient of 66  18 mm Hg. The average peak gradi-
ent of the remaining 107 patients without stenosis was
21  13 mm Hg.
DISCUSSION
The place of aortic valve repair in the armamentarium of
techniques to treat aortic valve disease in children is still
unclear. Historical series have demonstrated that balloon
valvuloplasty achieves similar results to surgery in termsThe Journal of Thoracic and Cardiovascular Surgery c Volume 145, Number 2 465
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Dof survival and reoperation rate. These comparisons no lon-
ger seem valid because the development of techniques of
valve repair started only in the mid-1990s after these com-
parative studies were completed. In recent years, there has
been a drop in enthusiasm for the Ross procedure, a tech-
nique that was initially promised to become the best option
in the pediatric age group.7,14,15 Recent follow-up studies
confirmed that at least one-quarter of the autografts would
fail in the first 20 years following the Ross procedure,
most of them because of the progressive dilatation of the
autograft.6,7 These alarming results may be improved by
the use of the inclusion technique, but this latter
technique is rarely possible in children.16 Six years after
the classic technique of root replacement in the pediatric
population, 97% of patients were found to have an autograft
root size z score>4.7 The current reports of outcomes of
aortic valve repair in children have mainly been limited to
series of cusp extension, mainly in patients with rheumatic
disease, and it has been difficult to establish the benefits of
a policy of aortic valve repair adopting all available
techniques.9,10
Our experience favoring valve repair over balloon dilata-
tion and Ross procedure gives insights to the outcomes
achievable by this approach. It was not our goal to achieve
a definitive repair in this population, but rather to postpone
valve replacement for as long as possible. As a result of this
policy, close to two-thirds of our patients remained free of
reintervention for up to 9 years. The patients undergoing
addition of glutaraldehyde preserved autologuous pericar-
dium seemed to be subjected to a constant rate of reopera-
tion and our study seems to confirm that all patients will
ultimately require a reintervention by 12 to 15 years. Inter-
estingly, our experience with cusp extension in congenital
aortic valve disease seems to match the experience reported
by the team working in Riyadh, Saudi Arabia,9 with the
same technique in rheumatic aortic valve disease. It has
now been reported that up to 80% of adults undergoing re-
pair without addition of patch material may remain free of
reintervention for a decade and, hopefully, a large propor-
tion of these patients will have long-lasting results.8 The
use of these techniques in children seems to be superior to
the results of cusp extension and we therefore believe that
aortic valve repair without patch material should be
favored, if feasible. Similar to the adult population, these
techniques of repair are mainly restricted to aortic regurgi-
tation. Neonates, infants, and small children present mainly
with congenital aortic stenosis with typically small aortic
roots necessitating a maximal enlargement of the effective
orifice area. In our experience, opening of unicuspid valves
into bicuspid valves and the tricuspidization of bicuspid
valves is necessary in these patients. The cusp extension
technique has been unavoidable in some of these cases. In
recent times, we have tried to avoid this technique by
performing alternate techniques such as resection of a fused466 The Journal of Thoracic and Cardiovascular Surgcommissure and recreation of a new commissure with trian-
gular patches or triangular resection of a raphe and patch
reconstruction of the defect.
Because patients were progressively preferentially
referred to surgery, aortic balloon valvuloplasty has been
virtually abandoned in our center and we can no longer
compare the results of aortic valve repair with this tech-
nique in a contemporary era. It appears, however, that our
overall results with valve repair are superior or at least
equivalent to best practices of balloon valvuloplasty.3
Although the freedom of reoperation of our patients is not
by far superior to balloon valvuloplasty, only a fraction of
them have required valve replacement, and we hope to
have ultimately a larger proportion of patients who will
not require any further reoperation. We also believe that pri-
mary repair will maintain the best quality of aortic valve
tissue giving better chances of a longer lasting repair. How-
ever, most of the patients on whom we operate at a young
age will ultimately require valve replacement. By perform-
ing a repair at young age, we hope to obtain growth of their
aortic root and to postpone the Ross procedure to a time
when they have reached a size allowing the use of tech-
niques preventing subsequent autograft root dilatation.17,18
Although the overall results of this policy of aortic valve
repair in children has been satisfactory, we have been con-
cerned by the ischemic complications that some of these pa-
tients developed after tricuspidisation and cusp extension. It
is only recently thatwehave been able to demonstrate that the
mechanism of this ischemiamay be related to the obstruction
of 1 coronary ostiumby the bulk of the patches.With increas-
ing experience with the cusp extension technique, one often
tends to use high patches to achieve reliable valve compe-
tence. These patches do not seem to cause obstruction of
the coronary ostia in symmetric tricuspid valves, but may
become obstructive in bicuspid valves made tricuspid.
Tricuspidisation often results in the creation of a smaller
cusp. We believe that, in this instance, the coaptation point
of the 3 newly re-created leaflets may occur close to the aor-
tic wall, and that the edge of the patch facing this small cusp
may flick toward the wall and occlude the coronary ostium.
It has not been possible to prove retrospectively that this
mechanism was the cause for the 3 dramatic events ob-
served in this series. Sudden death has been shown to occur
even after balloon valvuloplasty and other mechanisms may
have been responsible for the sudden deaths observed.19 We
believe that surgeons should use ultimate caution when per-
forming tricuspidization and cusp extension in patients with
bicuspid valve, and pay a particular attention not to use
patches that are too high and may become redundant. We
hope that a raised awareness toward ischemic complications
may prevent the occurrence of these adverse events. Up to
this stage, simpler procedures do not seem to warrant better
outcomes, but this finding may be related to the limited
number of patients in this series.ery c February 2013
d’Udekem et al Congenital Heart DiseaseLimitations
At the beginning of our study period patients were
offered either balloon valvuloplasty or surgery, thereby pos-
sibly constituting a selection bias. Accordingly, a large
number of patients were operated in recent times, restricting
the number of available data for long-term follow-up.C
H
DCONCLUSIONS
A policy of aortic valve repair in pediatric populations is
effective in postponing reintervention. The longevity of the
repair is shorter after cusp extension and when performed in
infants. Caution should be used when performing tricsupid-
ization and cusp extension of bicuspid valves because it can
be responsible for mortality related to occlusion of the
coronary ostia by patches.References
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Dr Kristine Guleserian (Dallas, Tex). Let me start by congrat-
ulating you and Dr Brizard and the rest of the Melbourne group for
the excellent presentation and the very well-written manuscript
that I had a chance to review before this presentation of your expe-
rience over the past 13 years with 142 patients. Thirty of those
patients were less than a year of age, and 13 were neonates who
had undergone aortic valve repair with 80% freedom from reinter-
vention at 7 years, and two-thirds—or 66%—with freedom from
intervention at 9 years.
This is certainly a challenging group of patients for whomwe all
would like to provide a very durable and safe repair to help delay
subsequent reintervention, whether it’s re-repair; Ross procedure;
aortic valve replacement; or, in rare instances, cardiac transplanta-
tion. And of course, primary aortic valve repair is always favorable
with a goal to recapitulate normal aortic anatomy and physiology;
however, this is not always possible, and cusp extension or leaflet
extension procedures often, along with tricuspidization, are
required.
Drs Polimenakos, Ilbawi, and the Chicago group published their
results with aortic cusp extension using selective tricuspidization
in infants and children with actuarial freedom from reintervention
of 97%, 71%, and 56% at 1, 5, and 10 years. So those are pretty
similar.
And Dr Bacha and the Boston group have shown very good in-
termediate results with surgical aortic valvuloplasty, 80% of which
incorporated pericardial cusp extension for children and adoles-
cents with aortic insufficiency and no more than really moderate
aortic stenosis with freedom from intervention of 72% at 5 years
and 54% at 7.5 years.
In your presentation you point out the potential shortcomings of
cusp extension with respect to the shorter longevity of repair, par-
ticularly in the infant subgroup, and the development of what we
are calling presumed myocardial ischemia in the subset of patients
with the adverse events that you just outlined. You therefore urge
caution when employing the techniques.
So I have several questions for you. Is it possible that earlier in
the experience there was a learning curve associated with doing
these repairs that resolved after learning to recognize these events?
Dr Yves d’Udekem (Parkville, Victoria, Australia). We had
a lot of discussion mainly between Christian Brizard and myself
about what we would do with these complications and we are
divided. He tends to believe that we should get away from this
technique for bicuspid valve. I tend to still do them for bicuspid
aortic valve.
I think that we have in our practice operations that carry dan-
gers, and it’s not because there are complications that we should
avoid them. It is important for us to realize that there is a risk ofrdiovascular Surgery c Volume 145, Number 2 467
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Ddeath after an operation; therefore, if you’re not comfortable to do
them, then you should avoid them. If you are comfortable to do
them, you should exercise caution so that these complications do
not arise. So I leave it to individual surgeons to decide what to do.
Dr Guleserian. I agree with that. My second question is, again,
since you’ve recognized these events, what specific things have
you changed in terms of the technique? Please comment about
the glutaraldehyde fixation of the pericardial patches. Has there
has been any change in that technique in this time period?
Dr d’Udekem. Regarding the techniques, I think that if you
have a bicuspid valve, you should make sure that the coaptation
of the 3 cusps is central and not eccentric or close to the wall—
that’s what precipitates the prolapse of the free edge of the leaflet
toward the sinus.
Regarding the level of preparation of the pericardium, we are
gentler now than in the past. We moved from 6 to 8 minutes prep-
aration with glutaraldehyde to 2 baths of 2minutes in a flat fashion,
in a special press that we have for the pericardium. And then we do
full rinsing. I believe it is very important is to have a rinsing with
magnesium chloride in the final solution because that detoxifies
the glutaraldehyde. It is apparently important.
Dr Guleserian. A lot of other groups have decreased the
amount of time of fixation from 10 to somewhere around 5 to 6
and added further modifications.
Not surprisingly in the infant patient group those patients
tended to have a shorter durability of their repairs. My last question
is: Do you have any insight on how to provide this particular sub-
group with a more durable repair over time, particularly if they are
undergoing tricuspidization?
Dr d’Udekem. I’m glad you asked this question. We’ve
reviewed specifically our experience with children aged<1 year
and we’ve been able to compare our experience with surgery ver-
sus balloon dilatation. In the present work we excluded those who
had balloon commissurotomy. But when we looked at the aortic
valve surgery that was done in neonates—I think we had a group
of about 130 patients with close to 80 of those patients younger
than age 1 year—the result was absolutely stunningly in favor of
surgery. The freedom from reoperation was far better in the
patients operated on using this technique. The frequent techniques
were debulking of the valve and creation of neocommissure for
unicuspid valve. We didn’t do just simple blade commissurotomy
and just stick the blade through the valve, we did some more
refined work.
Most interesting is that by the time of 10 years follow-up, 20%
of patients who had a balloon valvuloplasty only were free of
reintervention and of residual stenosis or regurgitation, whereas
40% of those who had surgery were still free of any reintervention
and any aortic valve disease. That’s a manuscript that’s coming up.
Dr Gerhard Ziemer (Chicago, Ill). You showed a picture of
your Thoratec patient. This was a pretty tall patient and you had
to resuscitate him early after surgery. Was this a case of valvular
insufficiency in aMarfan patient?Would you do this type of plastic
in a Marfan patient?
Dr d’Udekem. The only surgery that we perform today in
Marfan patients is aortic root valve-sparing procedure. During
the past 5 years, at least, we have been able to repair all of them
with the David procedure. The patient you saw in that picture
had a stenotic bicuspid aortic valve with quite thick myocardium.468 The Journal of Thoracic and Cardiovascular SurgDr Ziemer. And a bicuspid Marfan’s aortic valve, would you
reconstruct it?
Dr d’Udekem. I would tend to repair all of them, yes.
DrKhanhNguyen (New York, NY). In the group that developed
ischemia, I noticed that 1 sinus tends to be small. We encountered
a similar situation in the operating room and the diagnosis was
made by echo. The extended cusp seemed to close off the sinus.
The maneuver that we tried was to enlarge the sinus and the ische-
mia went away. If you see a patient with this particular finding,
would you try to do something like that to restore flow?
Dr d’Udekem.We didn’t think about enlarging the sinus. As all
of you know, there are a few articles about cusp extension tech-
nique, but this issue was not yet described. I think it’s important
that it’s written that this problem can happen so that surgeons can
do either what you’ve done, or what we’ve done, and prevent it.
Dr Nguyen. The neonatal group that had the complete 3-leaflet
extension—how many of them in your series?
Dr d’Udekem. The complete 3-leaflet extension was done in 35
patients.
Dr Nguyen. And did you find that technically it’s harder to do
because the valves tend to be thinner and the roots are very small?
Any tips on the technique to extend those valves in neonatal
patients?
Dr d’Udekem. In neonates younger than 1 year, we found out
that generally speaking the disease is predominantly stenotic and
we have to—to have a durable repair—increase the effective ori-
fice area. We’ve tried to repair stenotic bicuspid valve at age 1,
2, and 3 years by leaving them bicuspid and that usually fails.
So if we have a bicuspid valve in a child of that age, we make it
tricuspid. If we have a neonate with a unicuspid valve, then we
tend to put new commissures with 2 triangular patches and we
make the valve bicuspid. It’s difficult to change a unicuspid valve
into a tricuspid valve in a neonate, but it is possible. My colleague
Igor did that recently. It’s very small. We found it difficult. So we
just make it bicuspid.
Dr Giovanni Stellin (Padova, Italy). I would like to congratu-
late you and Christian Brizard for these excellent results. A 60%
freedom from reoperation is an excellent result.
One or 2 patients needed reoperation during the same hospital-
ization. I wonder whether your repair was successful in all pa-
tients, or if in some instance it wasn’t judged successful in the
operating room and you had to carry on with the valve
replacement?
Dr d’Udekem.What happens is that we look at the valve and we
make the decision between Ross procedure and valve repair in the-
ater. And that’s what we tell patients. So far we have not found that
echo allowsus to predict in advancewhether or notwe can do a repair.
The idea now is that if we have a 4- or 5-year old, we can almost
always repair the valve, and that’s the beauty of the cusp exten-
sions. It has to be really extremely thick, it has to be a block of
fibrosis with no mobility on the hinge point of the leaflets for
you not to be able to repair.
If the valve is extremely dysplastic in a 14-, 15-, or 16-year old,
our threshold now is lower just to do a Ross procedure, because it’s
the time of the patient’s life where you want them to be free for 10
or 20 years without any problems. And we don’t want to operate at
age 16 years and have them back during the middle of their early
university years for a second operation.ery c February 2013
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DDr Stellin.Was any attempt to repair a valve turned into a valve
replacement?
Dr d’Udekem. I cannot remember any second run when we did
a Ross procedure and sowe did repair in all the patients. There was
only 1 patient in whom we did a Ross procedure during the same
hospital stay. We have some second runs to readjust the valve a lit-
tle bit at times, but the end result once we started to do a repair was
a repair.
Dr Emile Bacha (New York, NY). You’re talking about 2 prob-
lems with your cusp extensions: first is the acute coronary ische-
mia problem, which I believe a lot of people know about; and
second is the worse long-term outcomes. However, you have an in-
herent selection bias here because usually if you’re doing a cusp
extension, by definition the anatomy is going to be worse. I
don’t think that’s what you’re saying. You’re not saying that we
shouldn’t do cusp extension.
What are you proposing for the very bad valves? What do you
suggest at this point in time? Are you suggesting new techniques?The Journal of Thoracic and CaDr d’Udekem. I think cusp extension technique is a good tech-
nique. I think it’s worthwhile to repair aortic valves using this tech-
nique. It has the advantage of postponing reintervention for a fairly
long time. And I think that in congenital disease we will see results
similar to those that were published from Saudi Arabia for rheu-
matic aortic valve disease—the longevity of the repair will be be-
tween 5 and 15 years. I believe that by the end of 15 years all of the
patients will go back for reoperation.
But I believe that it’s a benefit to wait so that a patient can grow
to adult size. You can typically never do a Ross procedure with an
inclusion technique in these young children who have stenotic
valve. If you can wait until they reach adult size to have a Ross pro-
cedure, I think you can do a good inclusion technique. My belief is
that proceeding this way is going to provide the best future for
these patients with very bad disease.
Dr Bacha. On the other hand, the best subset of patients on
whom to do a Ross procedure is children with aortic stenosis.
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